Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.02 - $1.83 $14,737 - $26,441
-14,449 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$1.69 - $4.2 $24,418 - $60,685
14,449 New
14,449 $25,000
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $6,273 - $15,759
-5,019 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$6.86 - $9.97 $8,561 - $12,442
1,248 Added 33.09%
5,019 $36,000
Q2 2018

Aug 13, 2018

BUY
$2.88 - $8.67 $10,860 - $32,694
3,771 New
3,771 $26,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $819M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.